Incyte (INCY) and Genesis Therapeutics announced that the companies have entered into a strategic collaboration focused on the research, ...

Incyte is moving into Wilmington. The Delaware-founded, international pharmaceutical giant announced Tuesday afternoon that ...

For the next 15 years, biopharmaceutical firm Incyte Corp. will lease the former John Wanamaker building on Augustine Cut-off ...

Under the partnership, the companies intend to leverage the GEMS platform with Incyte's drug development experience to accelerate pharmaceutical research and create drug candidates with greater ...

Incyte is granted exclusive rights for potential clinical development and commercialization of collaboration products. “As a leader in pharmaceutical innovation, Incyte is continually seeking ...

(RTTNews) - Thursday, Incyte Corp. (INCY) and Genesis Therapeutics have entered into a strategic partnership focused on the research, discovery, and development of small molecule medicines.

with an initial focus on collaboration targets selected by Incyte…”As a leader in pharmaceutical innovation, Incyte is continually seeking new technologies that can transform how new medicines ...